Kwon Young Nam, Waters Patrick J, Kim Moonhang, Choi Youn Soo, Kim Jin Wook, Sung Jung-Joon, Park Sung-Hye, Kim Sung-Min
From the Department of Neurology (Y.N.K., J.-J.S., S.-M.K.), Seoul National University Hospital, Republic of Korea; Department of Neurology (Y.N.K.), Seoul National University Seoul Metropolitan Government Boramae Medical Center, Republic of Korea; Department of Medicine (Y.N.K.), Graduate School, Kyung Hee University, Republic of Korea; Neuroimmunology Group (P.J.W.), Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom; Biomedical Research Institute (M.K.), Seoul National University Hospital, Republic of Korea; Department of Medicine (Y.S.C.), Seoul National University, College of Medicine, Republic of Korea; Department of Neurosurgery (J.W.K.), Seoul National University Hospital, Republic of Korea; Department of Neurology (J.-J.S., S.-M.K.), Neuroscience Research Institute, Seoul National University, College of Medicine, Seoul, Republic of Korea; and Department of Pathology (S.-H.P.), Seoul National University, College of Medicine, Seoul, Republic of Korea.
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 1;6(5). doi: 10.1212/NXI.0000000000000600. Print 2019 Sep.